AISAP, a medical technology company specializing in AI-powered point-of-care ultrasound diagnostics, has partnered with Amavita Heart and Vascular Health...

Axena Health and Mayo Clinic have partnered to integrate Mayo Clinic’s overactive bladder (OAB) educational content into Axena Health’s...

Denali Therapeutics announced primary analysis results from a Phase 1/2 study of tividenofusp alfa (DNL310) in 47 participants with...

CytoDyn Inc. announced positive preclinical results for leronlimab, demonstrating a statistically significant reversal of liver fibrosis in three separate...

Wave Life Sciences has initiated a Phase 1 clinical trial, INLIGHT, for WVE-007, a novel RNA interference (RNAi) therapy...

Tonix Pharmaceuticals announced positive topline results from its Phase 1 single ascending dose trial of TNX-1500, an anti-CD40L monoclonal...

Trinity Biotech announced positive findings from a pre-pivotal trial of its next-generation continuous glucose monitoring (CGM) system, demonstrating significant...

Aclarion, Inc. launched its pivotal CLARITY trial at Northwestern Medicine, a leading clinical trial research center. The CLARITY trial...

Lipella Pharmaceuticals (Nasdaq: LIPO) has received FDA approval for an Expanded Access Program (EAP) for LP-310, an oral rinse...

Vaxxas, a clinical-stage biotech company, has appointed three prominent vaccine experts as advisors to guide product development and strategy....